GlassScriptPhysician profile
Roy Taoutel
NPI 1881221836
$3,526.24
in general payments reported to CMS, 2019-2025
16 companies · $2,208 in 2025
The $2,208 reported for 2025 was more than what 97% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $259 · 2022: $96.94 · 2023: $161 · 2024: $801 · 2025: $2,208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,749 · Education: $421.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,748.91 |
| Education | $420.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $802.50 | 2024-2025 | Ensite, Ensite Precision, Dragonfly Opstar |
| Medtronic, INC. | $472.71 | 2023-2025 | Resolute Onyx, Symplicity G3, Azure Xt Dr Mri Surescan |
| Kestra Medical Technology Services, INC. | $459.45 | 2025 | Assure Wcd |
| Boston Scientific Corporation | $413.67 | 2024-2025 | Avvigo Guidance System, Vigilant X4 Crt-D, Lux-Dx Insertable Cardiac Monitor |
| Astrazeneca Pharmaceuticals LP | $227.80 | 2021 | |
| Abiomed | $206.46 | 2024-2025 | Impella |
| Terumo Medical Corporation | $182.02 | 2025 | Metacross Otw |
| Shockwave Medical, INC | $159.72 | 2025 | |
| Pfizer INC. | $156.15 | 2021-2025 | |
| Bridgebio Pharma, INC. | $142.05 | 2025 | Attruby |
| Gilead Sciences, INC. | $96.94 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $75.79 | 2025 | Lifevest |
| Teleflex LLC | $50.90 | 2025 | Manta |
| Bracco Diagnostics INC. | $34.93 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.58 | 2025 | Entyvio |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $17.57 | 2025 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Taoutel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.